Evidence map›Paper›PMID 39355018›Full record

ReviewFrontiers in nuclear medicine2023

Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease.

Dineo Mpanya, Mike Sathekge, Eric Klug, Jenna Damelin, Stuart More, Bawinile Hadebe, Mariza Vorster, Nqoba Tsabedze

Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07563660 (Incremental Diagnostic and Prognostic Value of 68Ga-DOTA-SA-FAPI PET/CT Imaging in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07563660 narecruitingnot on this mapstarted 2025, after this paper: background citation

Incremental Diagnostic and Prognostic Value of 68Ga-DOTA-SA-FAPI PET/CT Imaging in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2025 to 2026Enrolled15ConditionsArrhythmogenic Right Ventricular Cardiomyopathy, FAPI PET, Cardiac Magnetic Resonance ImagingArms68Ga-DOTA-SA-FAPI PET/CT
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dineo MpanyaDivision of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Mike SathekgeDepartment of Nuclear Medicine, University of Pretoria, Pretoria, Gauteng, South Africa.
Eric KlugDivision of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Jenna DamelinDivision of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Stuart MoreDivision of Nuclear Medicine, Department of Radiation Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Bawinile HadebeDepartment of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
Mariza VorsterDepartment of Nuclear Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
Nqoba TsabedzeDivision of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gallium-68 fibroblast activation protein inhibitor [(

Indexed as

cardiovascular diseasefibroblast activation proteinfibrosisgallium-68myocardial injurypositron emission tomography

Identifiers

PMID39355018
PMCPMC11440833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.